Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 18,086 | 26,415 | 25,007 | 26,136 | 26,963 |
| Cost of Goods | 8,509 | 14,310 | 13,317 | 14,461 | 14,018 |
| Gross Profit | 9,577 | 12,105 | 11,690 | 11,675 | 12,945 |
| Operating Expenses | 10,436 | 13,538 | 12,820 | 12,976 | 13,184 |
| Operating Income | -350 | -1,123 | -813 | -840 | -221 |
| Interest Expense | 163 | 154 | 141 | 180 | 164 |
| Other Income | -237 | 289 | 74 | 253 | -58 |
| Pre-tax Income | -750 | -988 | -880 | -767 | -443 |
| Income Tax | -7 | 332 | 758 | -54 | 193 |
| Net Income Continuous | -743 | -1,320 | -1,638 | -713 | -636 |
| Net Income Discontinuous | -323 | N/A | N/A | N/A | N/A |
| Net Income | $-1,066 | $-1,320 | $-1,638 | $-713 | $-636 |
| EPS Basic Total Ops | -0.30 | -0.40 | -0.50 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | -0.20 | -0.39 | -0.48 | -0.21 | -0.19 |
| EPS Basic Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.30 | -0.40 | -0.50 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | -0.20 | -0.39 | -0.48 | -0.21 | -0.19 |
| EPS Diluted Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $583 | $-115 | $303 | $305 | $875 |